Decision No 2/2003 of the EC-Andorra Joint Committee

of 8 October 2003

laying down rules to implement further the Protocol on veterinary matters supplementary to the Agreement in the form of an Exchange of Letters between the European Economic Community and the Principality of Andorra, signed in Brussels on 15 May 1997

(2003/747/EC)

THE JOINT COMMITTEE,

Having regard to the Agreement in the form of an Exchange of Letters between the European Economic Community and the Principality of Andorra, hereinafter referred to as "the Agreement"(1), signed in Luxembourg on 28 June 1990, and in particular Article 17 thereof,

Having regard to the Protocol on veterinary matters supplementary to the Agreement in the form of an Exchange of Letters between the European Economic Community and the Principality of Andorra(2), signed in Brussels on 15 May 1997,

Whereas:

(1) The Contracting Parties desire to extend the traditional exchange of trade between Andorra and the European Community which were covered by Decision No 2/1999(3) and Decision No 1/2001(4) of the EC-Andorra Joint Committee in order to facilitate development of new exchanges.

(2) Such trade will accordingly be conducted in compliance with Community veterinary rules.

(3) At its meeting in Andorra on 13 and 14 December 2001, the veterinary subgroup of the EC-Andorra Joint Committee recommended the adoption of an additional list of Community legislation to be applied by Andorra in order to extend the agreement, the date of adoption to be no later than 18 months after the publication of this Decision in the Official Journal of the European Union,

HAS DECIDED AS FOLLOWS:

Article 1

General provision

Andorra undertakes to adopt Community measures in the field of control for transmissible spongiform encephalopathy (TSE) as set down in Article 2, Community measures on treatment of animal by-products not intended for human consumption as set down in Article 3 and Community measures against certain animal diseases as set down in Article 4.

Article 2

TSE legislation

Andorra will adopt Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies(5), as last amended by Commission Regulation (EC) No 1234/2003(6). For the purposes of this Agreement the following adaptations shall be made:

(a) in Annex III, Chapter A, Part II, point 2 of the table, the following shall be added:

">TABLE>"

(b) in Annex III, Chapter A, Part II, point 3 of the table, the following shall be added:

">TABLE>"

Andorra will adopt Council Decision 2000/766/EC of 4 December 2000 concerning certain protection measures with regard to transmissible spongiform encephalopathies and the feeding of animal protein(7), as last amended by Commission Decision 2002/248(8).

Andorra will adopt Commission Decision 2001/9/EC of 29 December 2000 concerning control measures required for the implementation of Council Decision 2000/766/EC concerning certain protection measures with regard to transmissible spongiform encephalopathies and the feeding of animal protein(9), as last amended by Decision 2002/248.

Article 3

Animal by-products

Andorra will adopt Regulation (EC) No 1774/2002 of the European Parliament and of the Council of 3 October 2002 laying down health rules concerning animal by-products not intended for human consumption(10), as last amended by Commission Regulation (EC) No 808/2003(11).

Article 4

Disease control measures

Andorra will adopt Council Directive 2001/89/EC of 23 October 2001 on Community measures for the control of classical swine fever(12) and Council Directive 2000/75/EC of 20 November 2000 laying down specific provisions for the control and eradication of bluetongue(13).

Article 5

Transposition and application

Andorra will transpose and apply, at the latest 18 months from the date of publication of this Decision in the Official Journal of the European Union, the Community legislation set down in the Annex.

Article 6

Entry into force

This Decision will enter into force on the first day of the month following that of its adoption.

Article 7

Publication

This Decision shall be published in the Official Journal of the European Union.

Done at Brussels, 8 October 2003.

For the Joint Committee

The President

Meritxell Mateu

(1) OJ L 374, 31.12.1990, p. 14.

(2) OJ L 148, 6.6.1997, p. 16.

(3) OJ L 31, 5.2.2000, p. 84.

(4) OJ L 33, 2.2.2002, p. 35.

(5) OJ L 147, 31.5.2001, p. 1.

(6) OJ L 173, 11.7.2003, p. 6.

(7) OJ L 306, 7.12.2000, p. 32.

(8) OJ L 84, 28.3.2002, p. 71.

(9) OJ L 2, 5.1.2001, p. 32.

(10) OJ L 273, 10.10.2002, p. 1.

(11) OJ L 117, 13.5.2003, p. 1.

(12) OJ L 316, 1.12.2001, p. 5.

(13) OJ L 327, 22.12.2000, p. 74.

ANNEX

References to these basic texts are to be understood as including references to all amendments and implementing rules

Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies.

Council Decision 2000/766/EC of 4 December 2000 concerning certain protection measures with regard to transmissible spongiform encephalopathies and the feeding of animal protein.

Commission Decision 2001/9/EC of 29 December 2000 concerning control measures required for the implementation of Council Decision 2000/766/EC concerning certain protection measures with regard to transmissible spongiform encephalopathies and the feeding of animal protein.

Regulation (EC) No 1774/2002 of the European Parliament and of the Council of 3 October 2002 laying down health rules concerning animal by-products not intended for human consumption.

Council Directive 2001/89/EC of 23 October 2001 on Community measures for the control of classical swine fever.

Council Directive 2000/75/EC of 20 November 2000 laying down specific provisions for the control and eradication of bluetongue.